Tigulixostat
Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor developed for research into hyperuricemia and gout. It effectively lowers uric acid levels in both cellular and animal models, making it a valuable tool for studying disease mechanisms and potential therapeutic approaches.
Product Specifications
CAS Number
1287766-55-5
Product Name Alternative
XanthineOxidase, Xanthine Oxidase, LC350189
Field of Research
Metabolism Research
Purity
98.07% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (11.21 mM) ; DMSO:80 mg/mL (271.82 mM)
Smiles
CC (C) n1cc (C#N) c2cc (ccc12) -n1cc (cn1) C (O) =O
Molecular Formula
C16H14N4O2
Molecular Weight
294.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
